SEARCH RESULT

Total Matching Records found : 112

Kumbh brought Allahabad to verge of an epidemic, says NGT -Banjot Kaur

-Down to Earth The tribunal has asked UP chief secretary to immediately act on the mismanaged solid waste from the pilgrimage Both the governments, at the Centre and Uttar Pradesh, claimed to have organised a 'swachh' — clean — Kumbh in the winter of 2018-19, but the National Green Tribunal seems to differ. In fact, the quasi judicial body rang alarm bells on Aprill 22, 2019 about host city Allahabad being on...

More »

Many essential drugs priced much higher than manufacturing cost: WHO -Sushmi Dey

-The Times of India NEW DELHI: Around 40% of the essential medicines in India with lowest MRP are priced significantly higher than estimated production costs, an assessment by the World Health Organisation (WHO) shows highlighting the “exorbitant” profiteering by pharmaceutical companies and the scope for lowering prices of drugs. While innovative and newer drugs for cancer, hepatitis C and rare diseases are out of reach of many due to their unaffordable prices,...

More »

India's abject failure on manual scavenging -Partha Pratim Mitra

-The Telegraph Despite being prohibited the practice remains widespread and unmodernised, and violators are not punished The death of five sanitation workers in Delhi is a grim reminder of the hostile conditions that confront manual scavenging in India. Manual scavenging has been prohibited by law. Yet, it remains unchecked. There is also a distinct lack of effort to make this objectionable occupation safe and dignified. This is the net result of institutional...

More »

Patent challenge to hepatitis-C medicines

-The Telegraph New Delhi: Patients' rights advocates in India on Tuesday filed two oppositions in the Indian patent office, challenging patent claims by the US pharmaceutical company Gilead Sciences for its medicines sofosbuvir and velpatasvir, used to treat hepatitis-C infections. The oppositions filed by the Delhi Network of Positive People (DNP+) challenge Gilead's patent applications for the tablet formulations of the fixed dose combination of sofosbuvir and velpatasvir and a new form...

More »

Whose development is it anyway? -TK Rajalakshmi and Akshay Deshmane

-Frontline.in The Assembly elections have put under intense scrutiny Narendra Modi’s Gujarat model of development which is touted as worthy of replication throughout the country. Audit reports of the CAG provide ample evidence of it being inefficient, corrupt and not beneficial to the common people. THE standard indicators of development, as is understood in theory and practice, comprise a range of indices, and not necessarily the level of private investment in...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close